SPS
MRTX

Susquehanna Portfolio Strategies’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-154,720
Closed -$9.09M – 997
2023
Q4 		$9.09M Buy
+154,720
New +$8.7M 0.16% 185

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna Portfolio Strategies's MRTX Position: Q1 2024 in Review

Susquehanna Portfolio Strategies sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 154,720 shares — an estimated $9.09M sold.

Susquehanna Portfolio Strategies first reported a position in MRTX in Q4 2023 and held it in 1 quarter. The position peaked at $9.09M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Susquehanna Portfolio Strategies reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 154,720 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $9.09M.
  • Susquehanna Portfolio Strategies first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Susquehanna Portfolio Strategies's Mirati Therapeutics, Inc. Common Stock position peaked at $9.09M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2024, filed 7 May 2024.